Studies involving disease:Multiple sclerosis
| Study ID | Study Title | Species | Institute |
|---|---|---|---|
| ST000688 | Biomarkers for different types of Multiple Scelerosis (MS) (BMS vs SPMS lipidomics) | Human | University of Michigan |
| ST002415 | Proteomics and metabolomics of multiple sclerosis | Mouse | Sharjah Institute for Medical Research |
| ST002416 | Proteomics and metabolomics of multiple sclerosis (Part 2) | Mouse | Sharjah Institute for Medical Research |
| ST002857 | Intracerebroventricular Transplantation of Foetal Allogeneic Neural Stem Cells in Patients with Secondary Progressive Multiple Sclerosis (hNSC-SPMS): a phase I dose-escalation clinical trial - Metabolomics Analysis of Human CSF | Human | University of Colorado Denver |
| ST002858 | Intracerebroventricular Transplantation of Foetal Allogeneic Neural Stem Cells in Patients with Secondary Progressive Multiple Sclerosis (hNSC-SPMS): a phase I dose-escalation clinical trial - Metabolomics Analysis of Human Serum | Human | University of Colorado Anschutz Medical Campus |
| ST003328 | Increased Cholesterol Synthesis Drives Neurotoxicity in Patient Stem Cell-Derived Model of Multiple Sclerosis - cellular lipidomics | Human | University of Colorado Denver |
| ST003330 | Increased Cholesterol Synthesis Drives Neurotoxicity in Patient Stem Cell-Derived Model of Multiple Sclerosis - media lipidomics | Human | University of Colorado Denver |
| ST003331 | Increased Cholesterol Synthesis Drives Neurotoxicity in Patient Stem Cell-Derived Model of Multiple Sclerosis - cellular metabolomics | Human | University of Colorado Denver |
| ST003332 | Increased Cholesterol Synthesis Drives Neurotoxicity in Patient Stem Cell-Derived Model of Multiple Sclerosis - media metabolomics | Human | University of Colorado Denver |
